This session provides an overview of pulmonary hypertension in patients receiving dialysis. What is the pathophysiology of pulmonary hypertension, who are the most vulnerable patients, and how is it diagnosed and treated? A discussion of the contraindications for kidney transplant are included.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 5/10/2025.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Consultant/Speakers Bureau for GSK Anemia.
Leah Foster Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF – Owner and Chief Education Officer for Interactive Nephrology

There are no other Planning Committee disclosures to declare.

Speaker Disclosures:

Naveed Masani – Research, Novo-Nordisk and Outset Medical; Advisory Board, Rockwell Medical

There are no other speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.

ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, discuss pulmonary hypertension among CKD patients, including pathophysiology, diagnosis, treatment, and contraindications for kidney transplant.

Credits Available